Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Biosimilars of infliximab were first approved by the European Medicine Agency in 2013, 1, 2
based on pre-clinical studies on biosimilarity and on clinical data coming from two …

1.1. Aim The overarching aim of ECCO is to improve the care of patients with IBD through
the development of guidelines, education and research. Current evidence is fundamental in …

The management of inflammatory bowel disease [IBD] is complex, and requires tight control
of disease activity, close monitoring to avoid treatment side effects, health care professionals …

V. Burisch J, Pedersen N, Cukovic-Cavka S, et al. Environmental factors in a population-
based inception cohort of inflammatory bowel disease patients in Europe–An ECCO …

Introduction: The best care setting for patients with inflammatory bowel disease [IBD] may be
in a dedicated unit. Whereas not all gastroenterology units have the same resources to …

Background Inflammatory bowel disease [IBD] includes chronic, disabling and progressive
conditions that need a complex approach and management. Although several attempts have …

Background One of the most valued targets in inflammatory bowel disease (IBD) is for
physicians to provide and patients to receive a high‐level quality of care. This study aimed to …

Background Acute severe ulcerative colitis (ASUC) is a potentially life‐threatening
complication of ulcerative colitis. Aim To develop consensus statements based on a …